Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2025-12-24 @ 3:06 PM
NCT ID:
NCT05434559
Eligibility Criteria:
Inclusion Criteria:
* People with T1D ≥18 years at the moment of switch to Insulin Degludec
* Diagnosed with T1D ≥2 years before switch to Insulin Degludec
* On basal-bolus insulin therapy with insulin pens ≥2 years before switch to Insulin Degludec
* ≥6 months use of Insulin Degludec at moment of datacollection
* Using continuous glucose monitoring ≥2 years before switch to Insulin Degludec
Exclusion Criteria:
* People with T1D \<18 years at the moment of switch to Insulin Degludec
* People without T1D or with T1D \<2 years before switch to Insulin Degludec
* Women with T1D who are pregnant or planning pregnancy during -12 and +12 months
* Not using basal-bolus insulin therapy with insulin pens during -24 and +6 months
* Start to use non-insulin antidiabetic agents between -12 and +12 months
* Having received treatment with oral or injectable corticosteroids during -12 and +12 months
* Undergoing hemodialysis, renal transplantation, or beta cell transplantation during -12 and +12 months
* \<6 months use of Insulin Degludec at moment of datacollection
* Not using continuous glucose monitoring or \<2 years before switch to Insulin Degludec
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05434559
Study Brief:
Protocol Section:
NCT05434559